ImmuCell Corp (ICCC) stock
ICCCNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/303% above fair value
$11.25−0.08 (-0.71%)
Close on Nov 18, 2026Market cap $102.18MP/E 140.6Yield –
ImmuCell shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
ImmuCell's shares outstanding was 9M at Jun 30, 2026. For fiscal 2025 it was 9M, up 10.5% from the year before. Over ten years it grew 11.0% a year on average. The highest annual figure on record is 9M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 9M | +10.5% |
| FY2024 | Dec 31, 2024 | 8M | +5.4% |
| FY2023 | Dec 31, 2023 | 8M | +0.0% |
| FY2022 | Dec 31, 2022 | 8M | +2.0% |
| FY2021 | Dec 31, 2021 | 8M | +5.3% |
| FY2020 | Dec 31, 2020 | 7M | +5.8% |
| FY2019 | Dec 31, 2019 | 7M | +24.3% |
| FY2018 | Dec 31, 2018 | 5M | +10.8% |
| FY2017 | Dec 31, 2017 | 5M | +14.1% |
| FY2016 | Dec 31, 2016 | 4M | +37.0% |
| FY2015 | Dec 31, 2015 | 3M | +4.6% |
| FY2014 | Dec 31, 2014 | 3M | -1.9% |
| FY2013 | Dec 31, 2013 | 3M | -0.8% |
| FY2012 | Dec 31, 2012 | 3M | +4.1% |
| FY2011 | Dec 31, 2011 | 3M | +0.5% |
| FY2010 | Dec 31, 2010 | 3M | +0.4% |
| FY2009 | Dec 31, 2009 | 3M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 9M | +1.7% |
| Q1 FY2026 | Mar 31, 2026 | 9M | +0.7% |
| Q4 FY2025 | Dec 31, 2025 | 9M | +1.1% |
| Q3 FY2025 | Sep 30, 2025 | 9M | +10.8% |
| Q2 FY2025 | Jun 30, 2025 | 9M | +15.6% |
| Q1 FY2025 | Mar 31, 2025 | 9M | +15.9% |
| Q4 FY2024 | Dec 31, 2024 | 9M | +15.4% |
| Q3 FY2024 | Sep 30, 2024 | 8M | +5.4% |
| Q2 FY2024 | Jun 30, 2024 | 8M | +0.8% |
| Q1 FY2024 | Mar 31, 2024 | 8M | +0.1% |
| Q4 FY2023 | Dec 31, 2023 | 8M | +0.0% |
| Q3 FY2023 | Sep 30, 2023 | 8M | 0.0% |
| Q2 FY2023 | Jun 30, 2023 | 8M | +0.0% |
| Q1 FY2023 | Mar 31, 2023 | 8M | -0.5% |
| Q4 FY2022 | Dec 31, 2022 | 8M | +0.0% |
| Q3 FY2022 | Sep 30, 2022 | 8M | -0.9% |
| Q2 FY2022 | Jun 30, 2022 | 8M | -0.2% |
| Q1 FY2022 | Mar 31, 2022 | 8M | +7.9% |
| Q4 FY2021 | Dec 31, 2021 | 8M | +7.3% |
| Q3 FY2021 | Sep 30, 2021 | 8M | +8.4% |
| Q2 FY2021 | Jun 30, 2021 | 8M | +7.6% |
| Q1 FY2021 | Mar 31, 2021 | 7M | +0.1% |
| Q4 FY2020 | Dec 31, 2020 | 7M | -0.0% |
| Q3 FY2020 | Sep 30, 2020 | 7M | +0.0% |
| Q2 FY2020 | Jun 30, 2020 | 7M | +0.0% |
| Q1 FY2020 | Mar 31, 2020 | 7M | +27.3% |
| Q4 FY2019 | Dec 31, 2019 | 7M | +31.1% |
| Q3 FY2019 | Sep 30, 2019 | 7M | +31.5% |
| Q2 FY2019 | Jun 30, 2019 | 7M | +31.5% |
| Q1 FY2019 | Mar 31, 2019 | 6M | +3.4% |
| Q4 FY2018 | Dec 31, 2018 | 6M | +14.6% |
| Q3 FY2018 | Sep 30, 2018 | 5M | +9.8% |
| Q2 FY2018 | Jun 30, 2018 | 5M | +13.1% |
| Q1 FY2018 | Mar 31, 2018 | 5M | +10.9% |
| Q4 FY2017 | Dec 31, 2017 | 5M | -0.2% |
| Q3 FY2017 | Sep 30, 2017 | 5M | +16.1% |
| Q2 FY2017 | Jun 30, 2017 | 5M | – |
| Q1 FY2017 | Mar 31, 2017 | 5M | – |
| Q4 FY2016 | Dec 31, 2016 | 5M | – |
| Q3 FY2016 | Sep 30, 2016 | 4M | – |
See a number that looks wrong?